News
1h
Zacks Investment Research on MSNVeeva vs. Salesforce: Which Life Sciences CRM Stock Is the Better Buy?A significant shift is underway in the enterprise software landscape, particularly within the life sciences customer relationship management (CRM) market. Veeva Systems VEEV, a long-time partner of ...
Additionally, it has enjoyed good customer retention throughout its cloud transition and is experiencing solid annual contract value growth. However, Pegasystems has displayed inconsistencies on the ...
Discover how financial advisors can leverage the right tech tools to streamline operations, enhance client experiences, and ...
In a Crunchbase News exclusive, San Francisco-based Ashby, provider of an “all-in-one” AI-powered HR platform, says it has ...
As major infrastructure initiatives like CRM become more essential, many firms find themselves struggling to get projects off the ground.
• Automatic Scaling: Cloud platforms can automatically handle increases in user demand. For example, during tax filing season ...
2d
Zacks Investment Research on MSNWhy Salesforce.com (CRM) is a Top Growth Stock for the Long-TermTaking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The research service ...
Check out the best CRM platforms that combine customer relationship management with email marketing automation -- featuring ...
We look at where a customer data platform sits alongside other technologies that offer features to boost customer experience ...
Wall Street estimates that AppLovin's earnings will increase by 55% annually through 2026. That makes the current valuation ...
Oakmark Funds, advised by Harris Associates, released its “Oakmark Fund” second quarter 2025 investor letter. A copy of the letter can be downloaded here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results